Your browser doesn't support javascript.
loading
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease.
Cybulla, Markus; Nicholls, Kathleen; Feriozzi, Sandro; Linhart, Ales; Torras, Joan; Vujkovac, Bojan; Botha, Jaco; Anagnostopoulou, Christina; West, Michael L.
Afiliación
  • Cybulla M; Center of Internal Medicine, Department of Nephrology and Rheumatology, Nephrologicum Markgräflerland MVZ, 79379 Müllheim, Germany.
  • Nicholls K; Department of Nephrology, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
  • Feriozzi S; Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia.
  • Linhart A; Nephrology and Dialysis Unit, Belcolle Hospital, 01100 Viterbo, Italy.
  • Torras J; Second Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
  • Vujkovac B; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Botha J; Faculty of Medicine, Campus Bellvitge, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Anagnostopoulou C; Department of Internal Medicine, Slovenj Gradec General Hospital, 2380 Slovenj Gradec, Slovenia.
  • West ML; Takeda Pharmaceuticals International AG, 8152 Zurich, Switzerland.
J Clin Med ; 11(16)2022 Aug 17.
Article en En | MEDLINE | ID: mdl-36013057

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Alemania